DOXYCYCLINE HYCLATE

DOXYCYCLINE HYCLATE was reported 68700 times

DOXYCYCLINE HYCLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 61 0.8714
1 GRIP STRENGTH 143 0.6245
2 CONGENITAL HIATUS HERNIA 118 0.5175
3 C-REACTIVE PROTEIN 470 0.5070
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 300 0.4491
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 898 0.4483
6 SWOLLEN JOINT COUNT 112 0.4480
7 JARISCH-HERXHEIMER REACTION 316 0.4438
8 LUPUS VULGARIS 532 0.4222
9 GASTROINTESTINAL MUCOSAL NECROSIS 56 0.3862
10 SWOLLEN JOINT COUNT INCREASED 1044 0.3271
11 ABORTION INCOMPLETE 553 0.2968
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 535 0.2580
13 RHEUMATIC FEVER 1134 0.2541
14 RETINITIS 428 0.2475
15 FACET JOINT SYNDROME 745 0.2286
16 DISLOCATION OF VERTEBRA 486 0.2129
17 X-RAY ABNORMAL 380 0.2123
18 RHEUMATOID FACTOR POSITIVE 1216 0.2103
19 OVERLAP SYNDROME 126 0.1800
20 DUODENAL ULCER PERFORATION 1277 0.1715
21 SERONEGATIVE ARTHRITIS 177 0.1545
22 BONE EROSION 522 0.1475
23 C-REACTIVE PROTEIN ABNORMAL 946 0.1473
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 914 0.1406
25 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 953 0.1329
26 HELICOBACTER INFECTION 1332 0.1295
27 PORPHYRIA ACUTE 179 0.1247
28 FOLLICULITIS 1243 0.1184
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 119 0.1121
30 MUSCLE INJURY 911 0.1098
31 PERIPHERAL VENOUS DISEASE 416 0.1018
32 HAND DEFORMITY 1318 0.1004
33 AUTOIMMUNE DISORDER 923 0.0946
34 DRUG TOLERANCE DECREASED 257 0.0914
35 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 51 0.0909
36 LIP DRY 823 0.0905
37 HYPERPARATHYROIDISM SECONDARY 224 0.0893
38 NEPHROGENIC ANAEMIA 403 0.0869
39 REBOUND ACID HYPERSECRETION 263 0.0869
40 GRANULOMA SKIN 71 0.0865
41 PEMPHIGUS 1047 0.0837
42 ENDOMETRITIS 55 0.0827
43 FIXED ERUPTION 141 0.0819
44 BREAST CANCER STAGE III 497 0.0767
45 HYPERCHOLESTEROLAEMIA 725 0.0750
46 SYNOVITIS 1344 0.0745
47 JOINT RANGE OF MOTION DECREASED 966 0.0720
48 SCIATICA 1127 0.0706
49 MALIGNANT MELANOMA IN SITU 87 0.0702
50 CHOLANGITIS SCLEROSING 135 0.0657
51 GRIP STRENGTH DECREASED 578 0.0656
52 PERICARDITIS 1083 0.0644
53 WOUND INFECTION 698 0.0637
54 GLOSSODYNIA 1394 0.0622
55 EXOSTOSIS 542 0.0593
56 IRRITABLE BOWEL SYNDROME 1219 0.0568
57 FIBROMYALGIA 1367 0.0562
58 BURSITIS 652 0.0537
59 LUPUS-LIKE SYNDROME 482 0.0531
60 LIVE BIRTH 440 0.0525
61 LYME DISEASE 173 0.0518
62 BREATH SOUNDS ABNORMAL 255 0.0517
63 RED BLOOD CELL SEDIMENTATION RATE INCREASED 560 0.0506
64 WOUND 1400 0.0500
65 WALKING AID USER 322 0.0488
66 PELVIC INFLAMMATORY DISEASE 72 0.0482
67 LOWER LIMB FRACTURE 917 0.0477
68 ASPERGILLUS INFECTION 311 0.0473
69 BLOOD PARATHYROID HORMONE DECREASED 70 0.0472
70 MATERNAL EXPOSURE TIMING UNSPECIFIED 175 0.0465
71 OESOPHAGEAL ULCER 179 0.0465
72 JOINT DISLOCATION 471 0.0445
73 GASTROINTESTINAL INJURY 118 0.0438
74 END STAGE RENAL DISEASE 794 0.0435
75 LIVER INJURY 1058 0.0431
76 FOOT DEFORMITY 474 0.0427
77 BRONCHIAL HYPERREACTIVITY 51 0.0424
78 IMPAIRED HEALING 1360 0.0414
79 HIDRADENITIS 375 0.0411
80 TYPE 2 DIABETES MELLITUS 1363 0.0404
81 OBESITY 615 0.0386
82 SYSTEMIC LUPUS ERYTHEMATOSUS 1368 0.0385
83 PULMONARY FIBROSIS 696 0.0362
84 PRESCRIBED OVERDOSE 700 0.0361
85 ROSACEA 165 0.0354
86 CHRONIC KIDNEY DISEASE 2628 0.0346
87 PULMONARY FUNCTION TEST ABNORMAL 53 0.0340
88 PANNICULITIS 79 0.0326
89 HIP ARTHROPLASTY 497 0.0324
90 METHAEMOGLOBINAEMIA 75 0.0324
91 CONTRAINDICATED PRODUCT ADMINISTERED 973 0.0321
92 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 79 0.0319
93 PSORIATIC ARTHROPATHY 1297 0.0319
94 INFUSION SITE DISCHARGE 55 0.0313
95 CHOLESTATIC LIVER INJURY 69 0.0310
96 PRESCRIBED UNDERDOSE 618 0.0309
97 WHEEZING 1797 0.0303
98 SPONDYLITIS 110 0.0302
99 HEPATIC CIRRHOSIS 565 0.0300
100 BENIGN PROSTATIC HYPERPLASIA 152 0.0294
101 DERMATITIS ACNEIFORM 178 0.0292
102 PULMONARY PAIN 85 0.0291
103 RHEUMATOID NODULE 79 0.0287
104 LOWER RESPIRATORY TRACT INFECTION 1294 0.0284
105 OESOPHAGITIS 310 0.0283
106 ONYCHOMADESIS 119 0.0283
107 BRONCHIECTASIS 189 0.0280
108 ROAD TRAFFIC ACCIDENT 1140 0.0272
109 PREGNANCY 545 0.0272
110 BLISTER 1506 0.0268
111 IDIOPATHIC INTRACRANIAL HYPERTENSION 60 0.0267
112 OSTEOARTHRITIS 1119 0.0264
113 PHOTOSENSITIVITY REACTION 434 0.0263
114 GAIT INABILITY 877 0.0262
115 CYTOPENIA 320 0.0261
116 INTRACRANIAL PRESSURE INCREASED 140 0.0251
117 BLOOD CHOLESTEROL INCREASED 1168 0.0250
118 PUSTULE 59 0.0249
119 EAR INFECTION 651 0.0244
120 KNEE ARTHROPLASTY 514 0.0244
121 SPINAL FUSION SURGERY 99 0.0244
122 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 406 0.0239
123 INFUSION SITE REACTION 70 0.0234
124 ARTHROPATHY 1300 0.0234
125 INJURY 1633 0.0232
126 INFUSION RELATED REACTION 1536 0.0232
127 HEPATIC ENZYME INCREASED 1575 0.0231
128 NIGHT SWEATS 733 0.0227
129 LUNG CONSOLIDATION 63 0.0225
130 ULCER HAEMORRHAGE 151 0.0223
131 LIVER DISORDER 987 0.0222
132 TUBULOINTERSTITIAL NEPHRITIS 417 0.0222
133 STOMATITIS 1333 0.0220
134 OEDEMA 1178 0.0217
135 TACHYARRHYTHMIA 54 0.0216
136 ISCHAEMIC CARDIOMYOPATHY 65 0.0212
137 JOINT STIFFNESS 554 0.0211
138 BLEPHAROSPASM 132 0.0209
139 MOBILITY DECREASED 1506 0.0209
140 PEMPHIGOID 158 0.0209
141 SINUSITIS 2143 0.0209
142 EYE INJURY 63 0.0207
143 DRUG TOLERANCE 102 0.0201
144 INFLAMMATION 1035 0.0200
145 PARONYCHIA 87 0.0198
146 DISCOMFORT 1206 0.0197
147 BREAST CANCER STAGE II 162 0.0195
148 TREATMENT FAILURE 1583 0.0191
149 OSTEOPOROSIS 778 0.0189
150 ECONOMIC PROBLEM 285 0.0188
151 C-REACTIVE PROTEIN INCREASED 682 0.0187
152 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 102 0.0187
153 DERMAL CYST 46 0.0187
154 INFUSION SITE PRURITUS 59 0.0187
155 DELIRIUM 648 0.0187
156 BLOOD PRESSURE DIASTOLIC ABNORMAL 47 0.0185
157 EAR PAIN 359 0.0184
158 LUNG DISORDER 890 0.0181
159 DRUG-INDUCED LIVER INJURY 568 0.0181
160 THERAPEUTIC PRODUCT EFFECT DECREASED 809 0.0180
161 THERAPY NON-RESPONDER 808 0.0180
162 ULCERATIVE KERATITIS 49 0.0179
163 DRUG INTOLERANCE 1686 0.0174
164 ABSCESS LIMB 74 0.0173
165 NAIL DISORDER 151 0.0172
166 SWELLING 1592 0.0170
167 ODYNOPHAGIA 101 0.0169
168 SUBCUTANEOUS ABSCESS 81 0.0169
169 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 811 0.0169
170 INFECTION 2436 0.0168
171 OBSTRUCTIVE AIRWAYS DISORDER 187 0.0168
172 FULL BLOOD COUNT ABNORMAL 176 0.0166
173 MUSCULOSKELETAL STIFFNESS 1450 0.0165
174 PAPILLOEDEMA 74 0.0164
175 PUSTULAR PSORIASIS 56 0.0163
176 UPPER RESPIRATORY TRACT INFECTION 749 0.0162
177 ANHEDONIA 425 0.0162
178 RHEUMATOID ARTHRITIS 1836 0.0162
179 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 277 0.0161
180 JOINT SWELLING 1937 0.0160
181 SLEEP DISORDER 1131 0.0160
182 ARTHRITIS INFECTIVE 74 0.0159
183 OESOPHAGEAL PAIN 63 0.0159
184 ILL-DEFINED DISORDER 961 0.0158
185 MUSCULOSKELETAL PAIN 827 0.0158
186 SUSPECTED OFF LABEL USE 71 0.0157
187 HYPERTRANSAMINASAEMIA 109 0.0157
188 TENDERNESS 163 0.0156
189 ACUTE KIDNEY INJURY 2379 0.0155
190 RASH VESICULAR 75 0.0155
191 CREPITATIONS 46 0.0154
192 SKIN NECROSIS 80 0.0154
193 GASTROINTESTINAL DISORDER 1381 0.0154
194 WEIGHT FLUCTUATION 160 0.0153
195 ASTHMA 1719 0.0152
196 INFUSION SITE HAEMORRHAGE 50 0.0152
197 DRY MOUTH 1221 0.0150
198 RENAL INJURY 446 0.0150
199 CUSHINGOID 48 0.0149
200 MOUTH SWELLING 86 0.0149
201 SUNBURN 111 0.0149
202 RENAL TUBULAR NECROSIS 145 0.0148
203 ARTHROPOD BITE 109 0.0147
204 MICTURITION URGENCY 165 0.0144
205 SKIN INFECTION 162 0.0144
206 LIVER FUNCTION TEST INCREASED 310 0.0144
207 POLYARTHRITIS 76 0.0144
208 DISABILITY 285 0.0144
209 CONTUSION 1378 0.0143
210 CHRONIC SINUSITIS 53 0.0141
211 PARANASAL SINUS DISCOMFORT 53 0.0140
212 INFUSION SITE SWELLING 88 0.0140
213 INFLAMMATORY MARKER INCREASED 69 0.0139
214 ONYCHOMYCOSIS 61 0.0139
215 CHOLECYSTITIS CHRONIC 93 0.0139
216 SPUTUM DISCOLOURED 131 0.0138
217 NORMAL NEWBORN 75 0.0138
218 SEASONAL ALLERGY 195 0.0138
219 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 107 0.0138
220 PANCREATITIS ACUTE 308 0.0137
221 GENERAL PHYSICAL HEALTH DETERIORATION 1580 0.0136
222 RENAL FAILURE 1813 0.0136
223 PAPULE 96 0.0136
224 INTENTIONAL PRODUCT USE ISSUE 1190 0.0136
225 BRONCHITIS 1005 0.0136
226 GASTROOESOPHAGEAL REFLUX DISEASE 1083 0.0134
227 ORAL CANDIDIASIS 177 0.0134
228 HYPOAESTHESIA 2007 0.0134
229 HORDEOLUM 58 0.0134
230 GASTRITIS EROSIVE 62 0.0133
231 PYODERMA GANGRENOSUM 47 0.0131
232 WOUND SECRETION 51 0.0130
233 CYSTIC FIBROSIS 72 0.0130
234 ABDOMINAL DISCOMFORT 2164 0.0129
235 DERMATITIS BULLOUS 93 0.0128
236 DRUG RESISTANCE 328 0.0128
237 HYPERVOLAEMIA 63 0.0127
238 TENDON PAIN 96 0.0127
239 PRE-EXISTING CONDITION IMPROVED 79 0.0126
240 AUTOIMMUNE HEPATITIS 88 0.0126
241 MELANOCYTIC NAEVUS 55 0.0125
242 MATERNAL EXPOSURE DURING PREGNANCY 1117 0.0125
243 RALES 72 0.0124
244 OSTEOPENIA 186 0.0122
245 MULTIPLE ALLERGIES 96 0.0122
246 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 665 0.0121
247 TOXIC EPIDERMAL NECROLYSIS 183 0.0120
248 HYPERSENSITIVITY 2229 0.0120
249 SKIN ULCER 310 0.0120
250 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 853 0.0120
251 PRODUCT ADMINISTRATION INTERRUPTED 94 0.0120
252 AMNESIA 776 0.0119
253 RESPIRATORY DISORDER 356 0.0119
254 CARDIOMEGALY 146 0.0119
255 UTERINE PERFORATION 100 0.0118
256 PRODUCTIVE COUGH 563 0.0118
257 PERIORBITAL SWELLING 66 0.0117
258 RASH PUSTULAR 85 0.0117
259 HALLUCINATIONS, MIXED 49 0.0116
260 PHOTOPHOBIA 219 0.0116
261 ARTHRITIS 915 0.0116
262 FURUNCLE 92 0.0116
263 FOREIGN BODY SENSATION IN EYES 74 0.0116
264 CYST 144 0.0116
265 PERIPHERAL SWELLING 1785 0.0116
266 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 298 0.0116
267 ULCER 184 0.0116
268 INFUSION SITE ERYTHEMA 97 0.0115
269 VAGINAL INFECTION 54 0.0115
270 BASAL CELL CARCINOMA 179 0.0115
271 HAEMORRHAGE 1199 0.0115
272 LIP SWELLING 381 0.0114
273 PATHOGEN RESISTANCE 104 0.0114
274 ATELECTASIS 110 0.0114
275 SPINAL OSTEOARTHRITIS 100 0.0114
276 URTICARIA 1889 0.0113
277 DYSPEPSIA 1109 0.0113
278 CELLULITIS 563 0.0112
279 SKIN MASS 74 0.0111
280 RENAL CYST 88 0.0111
281 NEPHROPATHY 103 0.0110
282 VASCULAR DEVICE INFECTION 50 0.0110
283 RHINITIS ALLERGIC 49 0.0110
284 STAPHYLOCOCCAL INFECTION 360 0.0109
285 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 568 0.0109
286 STEVENS-JOHNSON SYNDROME 240 0.0108
287 SKIN ABRASION 51 0.0108
288 INFUSION SITE PAIN 139 0.0108
289 DRUG ERUPTION 190 0.0107
290 CANDIDA INFECTION 181 0.0107
291 LYMPHOEDEMA 74 0.0107
292 SKIN LESION 291 0.0106
293 RESPIRATORY TRACT INFECTION 276 0.0106
294 DERMATITIS 222 0.0106
295 MYOSITIS 95 0.0106
296 HYPERTENSION 2242 0.0106
297 DERMATITIS CONTACT 120 0.0105
298 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 78 0.0104
299 PSEUDOMONAS INFECTION 89 0.0104
300 CONFUSIONAL STATE 1667 0.0103
301 FACIAL PAIN 92 0.0103
302 CLOSTRIDIUM DIFFICILE COLITIS 109 0.0103
303 INTERVERTEBRAL DISC DEGENERATION 95 0.0103
304 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 51 0.0102
305 HYPOMAGNESAEMIA 142 0.0102
306 SWELLING OF EYELID 64 0.0102
307 NODULE 133 0.0102
308 LOCALISED OEDEMA 47 0.0101
309 CHEST PAIN 1878 0.0101
310 SCAR 173 0.0101
311 TASTE DISORDER 205 0.0101
312 CONDITION AGGRAVATED 3044 0.0100
313 EYE PAIN 564 0.0100
314 COLITIS ULCERATIVE 442 0.0099
315 FREQUENT BOWEL MOVEMENTS 267 0.0099
316 LOCALISED INFECTION 239 0.0099
317 RASH PRURITIC 535 0.0099
318 SKIN PLAQUE 83 0.0098
319 CHEILITIS 53 0.0098
320 RASH 4255 0.0098
321 OSTEOMYELITIS 176 0.0097
322 UPPER-AIRWAY COUGH SYNDROME 80 0.0097
323 PERIPHERAL VASCULAR DISORDER 50 0.0097
324 OEDEMA PERIPHERAL 1179 0.0097
325 SKIN HYPERPIGMENTATION 83 0.0096
326 SWOLLEN TONGUE 300 0.0096
327 POST PROCEDURAL INFECTION 78 0.0096
328 SINUS CONGESTION 129 0.0095
329 NASOPHARYNGITIS 1759 0.0095
330 APPETITE DISORDER 63 0.0095
331 DYSPNOEA EXERTIONAL 355 0.0094
332 EOSINOPHILIA 164 0.0093
333 TOOTH ABSCESS 95 0.0093
334 MUSCULOSKELETAL CHEST PAIN 144 0.0093
335 HAEMOPTYSIS 259 0.0093
336 SKIN WARM 54 0.0093
337 MULTIPLE ORGAN DYSFUNCTION SYNDROME 262 0.0092
338 ACUTE RESPIRATORY FAILURE 177 0.0092
339 THERAPY PARTIAL RESPONDER 143 0.0092
340 ANXIETY 2600 0.0091
341 RASH MACULO-PAPULAR 203 0.0091
342 HERPES SIMPLEX 59 0.0091
343 BLOOD MAGNESIUM DECREASED 78 0.0090
344 WHITE BLOOD CELL COUNT INCREASED 346 0.0090
345 HEPATITIS 230 0.0090
346 PANCREATITIS 474 0.0090
347 ALOPECIA 1752 0.0089
348 VITAMIN D DEFICIENCY 87 0.0089
349 BACK INJURY 97 0.0089
350 CONGENITAL ANOMALY 69 0.0089
351 MAJOR DEPRESSION 65 0.0089
352 JOINT INJURY 190 0.0089
353 MIGRAINE 846 0.0089
354 EYE INFECTION 100 0.0088
355 DECREASED APPETITE 2054 0.0088
356 MEDICATION ERROR 491 0.0088
357 EXPOSURE DURING PREGNANCY 547 0.0088
358 TENDON DISORDER 57 0.0087
359 PULMONARY MASS 130 0.0087
360 PNEUMONIA BACTERIAL 80 0.0087
361 GINGIVITIS 47 0.0087
362 MENORRHAGIA 171 0.0087
363 CLOSTRIDIUM DIFFICILE INFECTION 190 0.0087
364 VASCULITIS 101 0.0087
365 RECTAL HAEMORRHAGE 371 0.0086
366 GASTRIC ULCER 164 0.0086
367 TENDONITIS 133 0.0086
368 NEUTROPENIC SEPSIS 61 0.0085
369 ABDOMINAL PAIN UPPER 1755 0.0085
370 HYPERCALCAEMIA 105 0.0085
371 PNEUMONIA 2753 0.0085
372 RIB FRACTURE 174 0.0085
373 ATRIAL FIBRILLATION 822 0.0084
374 JOINT EFFUSION 58 0.0084
375 CONJUNCTIVITIS 156 0.0084
376 INFUSION SITE EXTRAVASATION 52 0.0083
377 MUSCULAR WEAKNESS 948 0.0083
378 VOMITING 3919 0.0083
379 MUSCLE STRAIN 72 0.0083
380 HYPERLIPIDAEMIA 99 0.0083
381 HEPATIC CYTOLYSIS 105 0.0082
382 LABORATORY TEST ABNORMAL 243 0.0082
383 TINNITUS 377 0.0082
384 DIVERTICULUM 58 0.0082
385 SQUAMOUS CELL CARCINOMA OF SKIN 49 0.0081
386 PELVIC PAIN 147 0.0081
387 CHOLESTASIS 155 0.0081
388 PYREXIA 2790 0.0081
389 VISUAL IMPAIRMENT 998 0.0080
390 ECCHYMOSIS 55 0.0080
391 LEUKOCYTOSIS 145 0.0080
392 PHARYNGEAL SWELLING 78 0.0080
393 INFLAMMATORY BOWEL DISEASE 78 0.0080
394 ARTERIOSCLEROSIS 75 0.0080
395 TOOTH INFECTION 105 0.0080
396 SWELLING FACE 516 0.0079
397 SLEEP APNOEA SYNDROME 151 0.0079
398 SINUS HEADACHE 47 0.0079
399 QUALITY OF LIFE DECREASED 106 0.0079
400 THROMBOCYTOPENIA 877 0.0078
401 PRURITUS 3011 0.0078
402 SINUS DISORDER 155 0.0078
403 NECK PAIN 437 0.0078
404 DIARRHOEA HAEMORRHAGIC 73 0.0078
405 MOUTH ULCERATION 164 0.0078
406 DENTAL CARIES 86 0.0078
407 EYE SWELLING 287 0.0077
408 GASTRITIS 203 0.0077
409 PRODUCT USE IN UNAPPROVED INDICATION 1910 0.0077
410 ONYCHOCLASIS 53 0.0077
411 EYE DISCHARGE 80 0.0077
412 HYPERAESTHESIA 63 0.0077
413 DEPRESSION 1744 0.0077
414 OCULAR DISCOMFORT 86 0.0077
415 ORAL PAIN 171 0.0076
416 VITREOUS FLOATERS 75 0.0076
417 WEIGHT INCREASED 1708 0.0076
418 SUPRAVENTRICULAR TACHYCARDIA 73 0.0076
419 MULTIPLE INJURIES 48 0.0076
420 PANIC REACTION 55 0.0076
421 ABDOMINAL PAIN 1764 0.0076
422 CARPAL TUNNEL SYNDROME 106 0.0076
423 SCAB 86 0.0075
424 ABSCESS 120 0.0075
425 GROIN PAIN 66 0.0075
426 ADVERSE DRUG REACTION 673 0.0075
427 MEMORY IMPAIRMENT 1028 0.0075
428 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 66 0.0075
429 COELIAC DISEASE 73 0.0074
430 HEPATIC ENCEPHALOPATHY 69 0.0074
431 INCREASED TENDENCY TO BRUISE 68 0.0074
432 SKIN REACTION 104 0.0074
433 REBOUND EFFECT 83 0.0073
434 PULMONARY THROMBOSIS 80 0.0073
435 ADRENAL INSUFFICIENCY 89 0.0073
436 RHINITIS 59 0.0073
437 LEFT VENTRICULAR DYSFUNCTION 49 0.0073
438 DYSPNOEA 4139 0.0073
439 POST-TRAUMATIC STRESS DISORDER 49 0.0073
440 RESPIRATORY TRACT CONGESTION 116 0.0073
441 EPILEPSY 223 0.0073
442 SKIN FISSURES 142 0.0073
443 POSTOPERATIVE WOUND INFECTION 49 0.0072
444 LUNG INFILTRATION 64 0.0072
445 ARTERIOSCLEROSIS CORONARY ARTERY 48 0.0072
446 CARDIOMYOPATHY 107 0.0072
447 AORTIC ANEURYSM 55 0.0072
448 SQUAMOUS CELL CARCINOMA 68 0.0072
449 BACK DISORDER 117 0.0072
450 LIGAMENT SPRAIN 71 0.0072
451 SKIN DISORDER 239 0.0072
452 FLANK PAIN 67 0.0071
453 INSOMNIA 1896 0.0071
454 MUSCLE SPASMS 1303 0.0071
455 PARAESTHESIA 1112 0.0071
456 FUNGAL INFECTION 235 0.0070
457 JAUNDICE 189 0.0070
458 BRAIN FOG 110 0.0070
459 PHARYNGITIS 87 0.0070
460 CORONARY ARTERY DISEASE 212 0.0070
461 DEAFNESS 183 0.0070
462 BACTERAEMIA 83 0.0070
463 MALAISE 3059 0.0070
464 OROPHARYNGEAL PAIN 644 0.0069
465 ARTHRALGIA 2892 0.0069
466 DUODENAL ULCER 49 0.0069
467 COVID-19 PNEUMONIA 82 0.0069
468 INSURANCE ISSUE 105 0.0069
469 TACHYCARDIA 609 0.0068
470 TRANSIENT ISCHAEMIC ATTACK 231 0.0068
471 IMMUNODEFICIENCY 102 0.0068
472 UPPER GASTROINTESTINAL HAEMORRHAGE 115 0.0068
473 HICCUPS 56 0.0068
474 ANAEMIA 1301 0.0068
475 GASTROENTERITIS VIRAL 123 0.0068
476 INTERNATIONAL NORMALISED RATIO INCREASED 194 0.0068
477 PULMONARY TOXICITY 48 0.0068
478 PROTEINURIA 129 0.0068
479 FEBRILE NEUTROPENIA 450 0.0068
480 HYPOKALAEMIA 313 0.0068
481 DYSURIA 249 0.0068
482 FOOD ALLERGY 52 0.0067
483 SKIN LACERATION 73 0.0067
484 HYPOXIA 236 0.0067
485 GASTROINTESTINAL INFECTION 60 0.0067
486 RHINORRHOEA 432 0.0067
487 PNEUMOCYSTIS JIROVECII PNEUMONIA 67 0.0067
488 GAIT DISTURBANCE 1271 0.0066
489 PAIN 4072 0.0066
490 IRON DEFICIENCY ANAEMIA 61 0.0066
491 RASH MACULAR 231 0.0066
492 MYOCARDIAL ISCHAEMIA 75 0.0066
493 FEELING HOT 404 0.0066
494 BONE DISORDER 120 0.0066
495 ESCHERICHIA INFECTION 54 0.0066
496 PURPURA 58 0.0065
497 LIPASE INCREASED 50 0.0065
498 DERMATITIS ALLERGIC 82 0.0065
499 DEEP VEIN THROMBOSIS 423 0.0065
500 BLOOD PRESSURE DIASTOLIC DECREASED 48 0.0065
501 SMALL INTESTINAL OBSTRUCTION 80 0.0065
502 DIVERTICULITIS 180 0.0065
503 BACTERIAL INFECTION 121 0.0065
504 RASH ERYTHEMATOUS 309 0.0065
505 NAUSEA 5105 0.0064
506 APHTHOUS ULCER 50 0.0064
507 MASS 90 0.0064
508 DRY EYE 320 0.0064
509 SPINAL COMPRESSION FRACTURE 53 0.0064
510 DIARRHOEA 4136 0.0064
511 INTERVERTEBRAL DISC PROTRUSION 140 0.0064
512 EYE INFLAMMATION 61 0.0064
513 NEUROPATHY PERIPHERAL 607 0.0064
514 PHARYNGITIS STREPTOCOCCAL 69 0.0064
515 BODY TEMPERATURE INCREASED 130 0.0064
516 HEADACHE 3992 0.0064
517 EOSINOPHIL COUNT INCREASED 53 0.0064
518 CARDIAC MURMUR 55 0.0064
519 MALNUTRITION 71 0.0063
520 NEPHROLITHIASIS 291 0.0063
521 EMPHYSEMA 64 0.0063
522 WEIGHT DECREASED 1771 0.0063
523 FOOT FRACTURE 120 0.0063
524 SPLENOMEGALY 74 0.0063
525 PARAESTHESIA ORAL 91 0.0063
526 DRUG INTERACTION 1000 0.0063
527 GINGIVAL PAIN 50 0.0063
528 ACUTE RESPIRATORY DISTRESS SYNDROME 111 0.0063
529 MUSCULOSKELETAL DISCOMFORT 108 0.0063
530 MITRAL VALVE INCOMPETENCE 71 0.0063
531 HEAD DISCOMFORT 111 0.0063
532 TOOTH FRACTURE 69 0.0063
533 SKIN EXFOLIATION 528 0.0063
534 HIATUS HERNIA 81 0.0062
535 HAEMOLYTIC ANAEMIA 56 0.0062
536 BLOOD IRON DECREASED 74 0.0062
537 BONE DENSITY DECREASED 195 0.0062
538 COUGH 1745 0.0062
539 DRY THROAT 63 0.0062
540 PAIN IN EXTREMITY 1823 0.0062
541 NOCTURIA 75 0.0062
542 PRODUCT USE ISSUE 1161 0.0062
543 FATIGUE 4807 0.0062
544 THINKING ABNORMAL 115 0.0062
545 ACUTE HEPATIC FAILURE 84 0.0061
546 ILLNESS 633 0.0061
547 CHEST DISCOMFORT 629 0.0061
548 EAR DISCOMFORT 63 0.0061
549 FISTULA 69 0.0061
550 EMOTIONAL DISTRESS 741 0.0061
551 LIVER FUNCTION TEST ABNORMAL 178 0.0061
552 IMPAIRED GASTRIC EMPTYING 83 0.0061
553 ADVERSE EVENT 555 0.0060
554 PLEURAL EFFUSION 366 0.0060
555 PAIN IN JAW 170 0.0060
556 PULMONARY HYPERTENSION 125 0.0060
557 HAEMORRHOIDS 117 0.0060
558 ROTATOR CUFF SYNDROME 77 0.0060
559 RESTLESS LEGS SYNDROME 109 0.0060
560 DIZZINESS 2985 0.0060
561 OBSESSIVE-COMPULSIVE DISORDER 48 0.0060
562 CHROMATURIA 135 0.0060
563 EYE IRRITATION 344 0.0060
564 LIMB INJURY 162 0.0060
565 TRICUSPID VALVE INCOMPETENCE 47 0.0059
566 KIDNEY INFECTION 116 0.0059
567 PERIPHERAL COLDNESS 81 0.0059
568 BRONCHOSPASM 84 0.0059
569 LYMPHADENOPATHY 208 0.0059
570 ANAPHYLACTIC REACTION 324 0.0059
571 RENAL PAIN 62 0.0058
572 DECREASED ACTIVITY 63 0.0058
573 HAEMATEMESIS 148 0.0058
574 DEPRESSED MOOD 308 0.0058
575 PANCYTOPENIA 325 0.0058
576 TEMPERATURE INTOLERANCE 60 0.0058
577 PULMONARY EMBOLISM 552 0.0058
578 SPINAL DISORDER 55 0.0058
579 BLOOD COUNT ABNORMAL 88 0.0058
580 SKIN HAEMORRHAGE 86 0.0058
581 VIRAL INFECTION 193 0.0058
582 DYSPHAGIA 550 0.0058
583 HYPOGLYCAEMIA 281 0.0058
584 SEPSIS 645 0.0058
585 IMMUNOSUPPRESSION 51 0.0058
586 MUSCLE SPASTICITY 71 0.0058
587 TENDON RUPTURE 71 0.0057
588 PETECHIAE 60 0.0057
589 ASTHENIA 2162 0.0057
590 ENCEPHALOPATHY 141 0.0057
591 IMPAIRED QUALITY OF LIFE 82 0.0057
592 OVARIAN CYST 57 0.0057
593 LACRIMATION INCREASED 172 0.0057
594 TOOTHACHE 103 0.0057
595 LIMB DISCOMFORT 176 0.0057
596 ELECTROLYTE IMBALANCE 66 0.0057
597 INCONTINENCE 60 0.0057
598 CHOLELITHIASIS 186 0.0057
599 DECUBITUS ULCER 46 0.0056
600 PSORIASIS 736 0.0056
601 VENTRICULAR TACHYCARDIA 93 0.0056
602 OFF LABEL USE 4921 0.0056
603 RENAL IMPAIRMENT 472 0.0056
604 THERAPEUTIC RESPONSE DECREASED 339 0.0056
605 WRIST FRACTURE 67 0.0056
606 BLOOD POTASSIUM DECREASED 168 0.0056
607 PNEUMONITIS 152 0.0056
608 RESPIRATORY FAILURE 404 0.0055
609 ACNE 419 0.0055
610 OCULAR HYPERAEMIA 261 0.0055
611 GALLBLADDER DISORDER 98 0.0055
612 DISEASE RECURRENCE 261 0.0055
613 URINARY TRACT INFECTION 934 0.0055
614 GOUT 98 0.0055
615 DEFORMITY 51 0.0055
616 SNEEZING 122 0.0054
617 CHILLS 637 0.0054
618 BLOOD SODIUM DECREASED 102 0.0054
619 CYSTITIS 172 0.0054
620 SEPTIC SHOCK 235 0.0054
621 RESPIRATORY SYNCYTIAL VIRUS INFECTION 47 0.0054
622 NEURALGIA 131 0.0054
623 ASPIRATION 59 0.0054
624 PULMONARY CONGESTION 71 0.0054
625 SPINAL PAIN 63 0.0054
626 HOSPICE CARE 53 0.0054
627 PNEUMOTHORAX 85 0.0054
628 ERYTHEMA 1099 0.0053
629 URINARY INCONTINENCE 158 0.0053
630 ECZEMA 279 0.0053
631 MENTAL STATUS CHANGES 148 0.0053
632 NEUTROPENIA 724 0.0053
633 EPISTAXIS 398 0.0053
634 DIPLOPIA 138 0.0053
635 NERVE COMPRESSION 49 0.0053
636 HALLUCINATION, VISUAL 112 0.0053
637 OXYGEN SATURATION DECREASED 298 0.0053
638 ORAL HERPES 103 0.0053
639 SUICIDAL IDEATION 483 0.0053
640 PHARYNGEAL OEDEMA 81 0.0053
641 INITIAL INSOMNIA 54 0.0053
642 ANKLE FRACTURE 81 0.0052
643 ORTHOSTATIC HYPOTENSION 91 0.0052
644 COVID-19 915 0.0052
645 GLOMERULAR FILTRATION RATE DECREASED 64 0.0052
646 PAIN OF SKIN 140 0.0052
647 NASAL CONGESTION 305 0.0052
648 HEPATOMEGALY 51 0.0052
649 BACK PAIN 1202 0.0052
650 SYNCOPE 517 0.0052
651 APHONIA 72 0.0052
652 DIZZINESS POSTURAL 50 0.0052
653 RASH PAPULAR 115 0.0051
654 HYPERBILIRUBINAEMIA 53 0.0051
655 BLOOD ALKALINE PHOSPHATASE INCREASED 127 0.0051
656 HAEMATURIA 175 0.0051
657 SECRETION DISCHARGE 64 0.0051
658 BURNING SENSATION 356 0.0051
659 PANIC ATTACK 185 0.0051
660 SINUS BRADYCARDIA 49 0.0051
661 BLOOD CALCIUM DECREASED 57 0.0051
662 PRODUCT DISTRIBUTION ISSUE 47 0.0051
663 ABDOMINAL PAIN LOWER 128 0.0051
664 MULTIPLE FRACTURES 83 0.0050
665 HEPATIC STEATOSIS 94 0.0050
666 HYPOPHAGIA 129 0.0050
667 ALANINE AMINOTRANSFERASE INCREASED 309 0.0050
668 FLUID RETENTION 255 0.0050
669 DEVICE RELATED INFECTION 77 0.0050
670 PRESYNCOPE 121 0.0050
671 LETHARGY 286 0.0050
672 OSTEONECROSIS OF JAW 123 0.0050
673 MYALGIA 845 0.0050
674 TOOTH LOSS 103 0.0050
675 ORAL DISCOMFORT 69 0.0050
676 THROAT TIGHTNESS 134 0.0049
677 HYPERSOMNIA 142 0.0049
678 AGRANULOCYTOSIS 92 0.0049
679 NERVE INJURY 55 0.0049
680 IMMUNE SYSTEM DISORDER 65 0.0049
681 RETCHING 105 0.0049
682 COAGULOPATHY 82 0.0049
683 TREATMENT NONCOMPLIANCE 268 0.0049
684 HAEMATOCRIT DECREASED 97 0.0049
685 FAECES DISCOLOURED 106 0.0049
686 INFLUENZA 545 0.0049
687 NEUTROPHIL COUNT INCREASED 50 0.0049
688 BLOOD PRESSURE SYSTOLIC INCREASED 95 0.0049
689 TRANSAMINASES INCREASED 108 0.0049
690 HYPONATRAEMIA 273 0.0048
691 RASH GENERALISED 125 0.0048
692 DEHYDRATION 640 0.0048
693 ASCITES 141 0.0048
694 FEAR 129 0.0048
695 DYSPHONIA 279 0.0048
696 HERPES ZOSTER 273 0.0047
697 HAIR COLOUR CHANGES 59 0.0047
698 POOR QUALITY SLEEP 102 0.0047
699 POOR VENOUS ACCESS 49 0.0047
700 PRODUCT PRESCRIBING ISSUE 103 0.0047
701 FEELING JITTERY 90 0.0047
702 MUCOSAL INFLAMMATION 123 0.0047
703 ASPARTATE AMINOTRANSFERASE INCREASED 249 0.0047
704 DISEASE PROGRESSION 554 0.0047
705 POLLAKIURIA 195 0.0047
706 PALPITATIONS 546 0.0047
707 CARDIAC FAILURE CONGESTIVE 373 0.0046
708 TACHYPNOEA 63 0.0046
709 HAEMATOMA 120 0.0046
710 VENTRICULAR EXTRASYSTOLES 48 0.0046
711 HEART RATE IRREGULAR 104 0.0046
712 PRODUCT ADMINISTRATION ERROR 93 0.0046
713 PRODUCT DOSE OMISSION IN ERROR 130 0.0046
714 AGEUSIA 113 0.0045
715 SINUS TACHYCARDIA 64 0.0045
716 VISION BLURRED 617 0.0045
717 HEPATOTOXICITY 100 0.0045
718 SKIN DISCOLOURATION 206 0.0045
719 LEUKOPENIA 224 0.0045
720 PARANOIA 77 0.0045
721 CONSTIPATION 972 0.0045
722 HALLUCINATION 335 0.0044
723 POLYNEUROPATHY 53 0.0044
724 BLOOD PRESSURE FLUCTUATION 106 0.0044
725 CATARACT 262 0.0044
726 NIGHTMARE 152 0.0044
727 SHOCK 101 0.0044
728 DRY SKIN 586 0.0044
729 RESPIRATORY DISTRESS 121 0.0044
730 SURGERY 257 0.0044
731 SKIN CANCER 94 0.0044
732 NEPHROPATHY TOXIC 49 0.0044
733 GENERALISED OEDEMA 54 0.0044
734 HYPERTHYROIDISM 63 0.0043
735 THROAT IRRITATION 194 0.0043
736 POST PROCEDURAL COMPLICATION 83 0.0043
737 LUNG INFECTION 67 0.0043
738 ABDOMINAL DISTENSION 450 0.0043
739 PULMONARY OEDEMA 193 0.0043
740 PALLOR 117 0.0043
741 ABORTION SPONTANEOUS 172 0.0043
742 ANOSMIA 62 0.0043
743 PERICARDIAL EFFUSION 99 0.0043
744 CHOLECYSTITIS 51 0.0043
745 HYPOCALCAEMIA 81 0.0043
746 UPPER LIMB FRACTURE 85 0.0043
747 MUSCLE ATROPHY 54 0.0043
748 HYPOTHYROIDISM 136 0.0043
749 HYPOTENSION 853 0.0042
750 SARS-COV-2 TEST POSITIVE 56 0.0042
751 ANGIOEDEMA 187 0.0042
752 UNDERDOSE 308 0.0042
753 FULL BLOOD COUNT DECREASED 85 0.0042
754 THROMBOSIS 338 0.0042
755 FLUID OVERLOAD 61 0.0042
756 VERTIGO 255 0.0042
757 BALANCE DISORDER 361 0.0042
758 FEELING COLD 116 0.0042
759 EYE PRURITUS 140 0.0042
760 RED BLOOD CELL COUNT DECREASED 119 0.0042
761 BLOOD URINE PRESENT 79 0.0042
762 HEART RATE INCREASED 412 0.0042
763 HAEMATOCHEZIA 229 0.0041
764 TREMOR 687 0.0041
765 IMPAIRED DRIVING ABILITY 47 0.0041
766 MELAENA 91 0.0041
767 INTERSTITIAL LUNG DISEASE 200 0.0041
768 INTERNAL HAEMORRHAGE 47 0.0041
769 HYPOAESTHESIA ORAL 62 0.0041
770 DRUG INEFFECTIVE 5415 0.0041
771 LYMPHOPENIA 58 0.0041
772 SPINAL FRACTURE 82 0.0041
773 TOOTH DISORDER 91 0.0041
774 ELECTROCARDIOGRAM QT PROLONGED 147 0.0041
775 EATING DISORDER 87 0.0041
776 HIP FRACTURE 131 0.0041
777 PLATELET COUNT INCREASED 53 0.0041
778 BLOOD UREA INCREASED 68 0.0041
779 SPINAL OPERATION 50 0.0041
780 EYELID OEDEMA 47 0.0040
781 BONE PAIN 234 0.0040
782 PRODUCT DOSE OMISSION ISSUE 1169 0.0040
783 INTENTIONAL DOSE OMISSION 113 0.0040
784 COLITIS 150 0.0040
785 HEAD INJURY 124 0.0039
786 COLD SWEAT 69 0.0039
787 DIABETES MELLITUS 298 0.0039
788 LYMPHOCYTE COUNT DECREASED 69 0.0039
789 BONE MARROW FAILURE 79 0.0039
790 GINGIVAL BLEEDING 53 0.0039
791 MUSCLE TWITCHING 89 0.0039
792 BONE LOSS 58 0.0039
793 BLOOD PRESSURE ABNORMAL 76 0.0038
794 HYPERKALAEMIA 134 0.0038
795 CIRCULATORY COLLAPSE 65 0.0038
796 GENITAL HAEMORRHAGE 49 0.0038
797 HEPATOCELLULAR INJURY 54 0.0038
798 DRUG LEVEL INCREASED 63 0.0038
799 MIDDLE INSOMNIA 71 0.0038
800 SENSORY DISTURBANCE 61 0.0038
801 BLOOD CREATININE INCREASED 248 0.0038
802 RENAL FAILURE ACUTE 161 0.0038
803 DYSSTASIA 110 0.0038
804 GLAUCOMA 72 0.0037
805 HAIR TEXTURE ABNORMAL 50 0.0037
806 ACTIVITIES OF DAILY LIVING IMPAIRED 74 0.0037
807 RENAL DISORDER 174 0.0037
808 MOOD SWINGS 119 0.0037
809 EJECTION FRACTION DECREASED 58 0.0037
810 LOSS OF CONSCIOUSNESS 475 0.0037
811 MUSCLE TIGHTNESS 60 0.0037
812 HAEMOGLOBIN DECREASED 380 0.0037
813 HYPERHIDROSIS 476 0.0037
814 FALL 1228 0.0037
815 PRODUCT USE COMPLAINT 58 0.0037
816 INTENTIONAL PRODUCT MISUSE 321 0.0037
817 BLINDNESS 149 0.0037
818 HOT FLUSH 275 0.0036
819 SEROTONIN SYNDROME 70 0.0036
820 BLOOD PRESSURE INCREASED 557 0.0036
821 HYPOACUSIS 156 0.0036
822 BLOOD TRIGLYCERIDES INCREASED 64 0.0036
823 EYE DISORDER 119 0.0036
824 PROCEDURAL PAIN 100 0.0036
825 CRYING 131 0.0036
826 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 649 0.0036
827 PSYCHOTIC DISORDER 106 0.0036
828 DISTURBANCE IN ATTENTION 192 0.0036
829 DYSARTHRIA 134 0.0036
830 FACE OEDEMA 60 0.0036
831 IMPAIRED WORK ABILITY 76 0.0036
832 DISSEMINATED INTRAVASCULAR COAGULATION 50 0.0035
833 RESTLESSNESS 129 0.0035
834 HALLUCINATION, AUDITORY 56 0.0035
835 UNEVALUABLE EVENT 265 0.0035
836 GASTRIC DISORDER 120 0.0035
837 DERMATITIS ATOPIC 184 0.0035
838 MOVEMENT DISORDER 112 0.0035
839 THIRST 62 0.0035
840 ERECTILE DYSFUNCTION 89 0.0035
841 MENTAL IMPAIRMENT 84 0.0035
842 BLOOD POTASSIUM INCREASED 56 0.0034
843 CORONARY ARTERY OCCLUSION 47 0.0034
844 GASTROENTERITIS 50 0.0034
845 SUBDURAL HAEMATOMA 49 0.0034
846 HEART RATE DECREASED 120 0.0034
847 HERNIA 66 0.0034
848 PNEUMONIA ASPIRATION 85 0.0034
849 FEEDING DISORDER 69 0.0034
850 ARRHYTHMIA 159 0.0034
851 URINARY RETENTION 112 0.0034
852 BLOOD PRESSURE DECREASED 223 0.0034
853 DYSKINESIA 136 0.0033
854 FLATULENCE 188 0.0033
855 GASTROINTESTINAL HAEMORRHAGE 277 0.0033
856 NEUROTOXICITY 58 0.0033
857 THYROID DISORDER 51 0.0033
858 HOSPITALISATION 507 0.0033
859 FEELING ABNORMAL 788 0.0033
860 WHITE BLOOD CELL COUNT DECREASED 354 0.0033
861 SPEECH DISORDER 171 0.0033
862 THERAPEUTIC RESPONSE UNEXPECTED 146 0.0033
863 METABOLIC ACIDOSIS 104 0.0032
864 BLOOD BILIRUBIN INCREASED 87 0.0032
865 HEPATIC FAILURE 97 0.0032
866 COGNITIVE DISORDER 149 0.0032
867 MENTAL DISORDER 138 0.0032
868 MOOD ALTERED 86 0.0032
869 LOCAL SWELLING 55 0.0031
870 PRURITUS GENERALISED 68 0.0031
871 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 92 0.0031
872 MULTI-ORGAN FAILURE 54 0.0031
873 ANGINA PECTORIS 89 0.0031
874 DISORIENTATION 123 0.0031
875 CARDIAC FAILURE 249 0.0031
876 FLUSHING 315 0.0031
877 LACTIC ACIDOSIS 100 0.0031
878 PLATELET COUNT DECREASED 329 0.0031
879 UNRESPONSIVE TO STIMULI 79 0.0031
880 INTESTINAL OBSTRUCTION 115 0.0030
881 SKIN IRRITATION 139 0.0030
882 SOMNOLENCE 610 0.0030
883 NERVOUSNESS 158 0.0030
884 VAGINAL HAEMORRHAGE 131 0.0030
885 METASTASES TO LIVER 53 0.0030
886 OSTEONECROSIS 99 0.0030
887 FRACTURE 57 0.0030
888 PLASMA CELL MYELOMA 117 0.0030
889 MUSCULOSKELETAL DISORDER 57 0.0030
890 AGITATION 218 0.0030
891 SKIN BURNING SENSATION 211 0.0029
892 CARDIAC ARREST 242 0.0029
893 HYPERGLYCAEMIA 106 0.0029
894 DYSGEUSIA 216 0.0029
895 INFLUENZA LIKE ILLNESS 238 0.0029
896 EMOTIONAL DISORDER 89 0.0029
897 INCREASED APPETITE 55 0.0029
898 RHABDOMYOLYSIS 120 0.0029
899 METASTASES TO BONE 47 0.0029
900 IRRITABILITY 172 0.0029
901 THERAPY INTERRUPTED 204 0.0029
902 THERAPEUTIC RESPONSE SHORTENED 94 0.0028
903 BRADYCARDIA 150 0.0028
904 DIABETES MELLITUS INADEQUATE CONTROL 49 0.0028
905 PRODUCT DOSE OMISSION 180 0.0028
906 APHASIA 83 0.0027
907 CARDIAC DISORDER 257 0.0027
908 ERUCTATION 53 0.0027
909 SUICIDE ATTEMPT 166 0.0027
910 CHOKING 53 0.0027
911 ABNORMAL DREAMS 74 0.0027
912 ACUTE MYOCARDIAL INFARCTION 79 0.0027
913 BLOOD CREATINE PHOSPHOKINASE INCREASED 77 0.0027
914 CARDIO-RESPIRATORY ARREST 111 0.0027
915 FEMUR FRACTURE 82 0.0026
916 DEVICE DISLOCATION 115 0.0026
917 THERAPY CESSATION 135 0.0026
918 DYSTONIA 51 0.0026
919 TARDIVE DYSKINESIA 73 0.0026
920 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 59 0.0025
921 CARDIOVASCULAR DISORDER 64 0.0025
922 NEUTROPHIL COUNT DECREASED 100 0.0025
923 SEIZURE 283 0.0024
924 GAMMA-GLUTAMYLTRANSFERASE INCREASED 54 0.0024
925 INCORRECT PRODUCT ADMINISTRATION DURATION 52 0.0024
926 TOXICITY TO VARIOUS AGENTS 401 0.0024
927 PRODUCT AVAILABILITY ISSUE 54 0.0024
928 CEREBRAL INFARCTION 56 0.0023
929 VISUAL ACUITY REDUCED 75 0.0023
930 INTENTIONAL OVERDOSE 142 0.0022
931 NERVOUS SYSTEM DISORDER 69 0.0022
932 EXPOSURE VIA SKIN CONTACT 57 0.0022
933 NEEDLE ISSUE 63 0.0022
934 SEDATION 55 0.0021
935 ACCIDENTAL OVERDOSE 75 0.0020
936 INJECTION SITE SWELLING 157 0.0020
937 CONVULSION 117 0.0020
938 DEVICE BREAKAGE 83 0.0020
939 MALIGNANT NEOPLASM PROGRESSION 209 0.0020
940 HEPATIC FUNCTION ABNORMAL 76 0.0020
941 INJECTION SITE URTICARIA 49 0.0020
942 GLYCOSYLATED HAEMOGLOBIN INCREASED 50 0.0020
943 RESPIRATORY ARREST 53 0.0019
944 MENSTRUATION IRREGULAR 51 0.0019
945 AGGRESSION 95 0.0019
946 ABNORMAL BEHAVIOUR 74 0.0019
947 INJECTION SITE PRURITUS 125 0.0019
948 ABASIA 46 0.0019
949 ANAPHYLACTIC SHOCK 48 0.0019
950 DEMENTIA 52 0.0019
951 FOETAL EXPOSURE DURING PREGNANCY 149 0.0018
952 DEVICE ISSUE 163 0.0018
953 COMPLETED SUICIDE 151 0.0018
954 MYOCARDIAL INFARCTION 316 0.0018
955 NEOPLASM PROGRESSION 62 0.0018
956 CEREBROVASCULAR ACCIDENT 298 0.0018
957 DEATH 1504 0.0017
958 ANGER 59 0.0017
959 INJECTION SITE BRUISING 138 0.0017
960 WITHDRAWAL SYNDROME 70 0.0017
961 PRODUCT SUBSTITUTION ISSUE 95 0.0016
962 LUNG NEOPLASM MALIGNANT 67 0.0016
963 OVERDOSE 350 0.0016
964 MULTIPLE SCLEROSIS 77 0.0016
965 PRODUCT QUALITY ISSUE 218 0.0016
966 INJECTION SITE ERYTHEMA 198 0.0016
967 INJECTION SITE PAIN 486 0.0016
968 INJECTION SITE REACTION 109 0.0016
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 319 0.0016
970 INJECTION SITE MASS 58 0.0016
971 DRUG ADMINISTRATION ERROR 48 0.0016
972 BLOOD GLUCOSE INCREASED 294 0.0016
973 INCORRECT DOSE ADMINISTERED 354 0.0015
974 INJECTION SITE RASH 47 0.0015
975 NO ADVERSE EVENT 276 0.0015
976 BLOOD GLUCOSE DECREASED 70 0.0015
977 DRUG DOSE OMISSION 235 0.0014
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 101 0.0014
979 DEPRESSED LEVEL OF CONSCIOUSNESS 56 0.0014
980 NEOPLASM MALIGNANT 94 0.0014
981 PRODUCT STORAGE ERROR 118 0.0013
982 DRUG ABUSE 112 0.0013
983 DRUG EFFECT DECREASED 66 0.0012
984 DEVICE MALFUNCTION 83 0.0012
985 ACCIDENTAL EXPOSURE TO PRODUCT 113 0.0011
986 MULTIPLE SCLEROSIS RELAPSE 74 0.0011
987 COMA 50 0.0010
988 INJECTION SITE HAEMORRHAGE 83 0.0010
989 DRUG WITHDRAWAL SYNDROME 82 0.0009
990 DRUG DEPENDENCE 145 0.0009
991 DEVICE DIFFICULT TO USE 51 0.0008
992 BREAST CANCER 53 0.0006